Abstract: In this paper, a new neuro-musculoskeletal simulator of human locomotor system is presented. This simulator is dedicated to reproduce healthy or altered walking gaits. It contains three ...
NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravis Aarhus, Denmark, 10 March 2026 – NMD Pharma A/S, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results